Smoking Cessation Aids Market Global Analysis & Forecast 2028
禁煙補助薬市場は、2021年の234億1,308万米ドルから2028年には640億3,230万米ドルに達すると予想されています。市場は2021年から2028年にかけて15.5%のCAGRで成長すると予測されています。
この禁煙補助薬市場の成長を牽引している主な要因は、 喫煙に対する依存症の増加、喫煙とタバコ依存を減らすキャンペーンの増加です。しかし、ニコチン代替療法の開発にかかるコストの高騰により、今後数年間の市場成長はある程度抑制される可能性があります。
市場分析
喫煙依存症の増加
ニコチンはタバコに含まれる非常に中毒性の高い物質です。タバコの喫煙は慢性的な健康状態、予防可能な病気、死亡、障害につながる可能性があるため、あらゆる形で危険であることが証明されています。世界保健機関(WHO)によると、喫煙関連の障害により米国では年間約435,000人が死亡しており、これは国内の総死亡者の約5人に1人に相当します。米国疾病管理予防センター(CDC)によると、2018年には米国の成人約4,000万人がタバコを吸っていました。さらに、約470万人の中学生と高校生が少なくとも1つのタバコ製品を使用し、米国の18歳未満の若者約1,600人が初めてタバコを吸いました。毎年、約50万人の患者が喫煙による病気で亡くなっています。米国政府は、米国で喫煙関連の症状に苦しむ患者の医療費として約2,250億ドルを費やしています。そのため、世界中のさまざまな国で喫煙の蔓延率が高くなっています。
要件に合わせて調査をカスタマイズ
弊社の標準サービスでは対応できない分析と範囲を最適化し、カスタマイズすることができます。この柔軟性により、ビジネス計画と意思決定に必要な正確な情報を得ることができます。
禁煙補助薬市場:
CAGR (2021 - 2028)15.5%- 市場規模 2021年
234.1億米ドル - 市場規模 2028年
640.3億米ドル
市場の動向
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
- XXXXXXXXX
主要人物
- ファイザー株式会社
- グラクソ・スミスクライン
- ドクター・レディの研究所
- ジョンソン・エンド・ジョンソン・サービス株式会社
- シプラ株式会社
- ペリゴ カンパニー
- バウシュヘルスカンパニーズ株式会社
- グレンマーク
- 楽しんで
地域概要
- 北米
- ヨーロッパ
- アジア太平洋地域
- 南米と中央アメリカ
- 中東およびアフリカ
市場セグメンテーション
- ニコチン置換療法
- 薬物
- 電子タバコ
- その他
- 病院薬局
- オンラインチャンネル
- 小売薬局
- その他のエンドユーザー
- サンプル PDF では、定性的および定量的な分析により、コンテンツの構造と情報の性質が紹介されています。
ヨーロッパやアジアのさまざまな国で状況は似ています。ギリシャ、ブルガリア、フランス、クロアチアは、ヨーロッパでタバコを多く消費する国です。健康指標評価研究所によると、ヨーロッパでは喫煙は非常に一般的な依存症で、15歳以上の成人の20%以上が毎日喫煙しています。さらに、世界人口レビューによると、ヨーロッパでは東南アジアとバルカン半島で喫煙率が最も高くなっています。WPRはまた、南アジアと東南アジアのさまざまな国で、男性の喫煙率が高い傾向があることを示唆しています。たとえば、インドネシアでは、2018年の男性の喫煙率は76.20%でした。このように、世界中で喫煙人口が増加していることが、世界の禁煙補助薬市場の成長を牽引しています。
製品ベースの洞察
製品に基づいて、禁煙補助市場は、ニコチン置換療法、薬物、電子タバコ、その他に分類されます。電子タバコは、タバコの健康的な代替品と見なされており、予測期間中に最も急速に成長するセグメントになると推定されています。電子タバコは、タバコに関連する健康状態を軽減するための効果的な代替品ですが、ニコチン置換療法は禁煙に最適です。電子タバコは、タバコベースのタバコに対する潜在的な脅威です。さらに、電子タバコの消費は通常のタバコに比べて害が少なく、煙が出ず、受動喫煙のリスクがなく、禁煙場所でも使用が許可されており、ニコチンレベルが異なり、さまざまなフレーバーが用意されていることが、電子タバコ市場の主な推進要因の一部です。さらに、電子機能に裏打ちされた電子タバコの人気の高まりは、需要の増加に貢献する主な要因です。
エンドユーザーベースの洞察
エンドユーザーに基づいて、禁煙補助薬市場は、病院薬局、オンラインチャネル、小売薬局、およびその他のエンドユーザーに分割されています。小売薬局セグメントは2021年に市場で最大のシェアを占める可能性がありますが、オンラインチャネルセグメントは予測期間中に市場で最も高いCAGRを記録すると予想されます。
ファイザー社、グラクソ・スミスクライン社、ドクター・レディーズ・ラボラトリーズ社、ジョンソン・エンド・ジョンソン・サービシズ社、シプラ社、ペリゴ社、バウシュ・ヘルス社、グレンマーク社、NJOY、ジュール・ラボラトリーズなどの主要企業は、収益と市場での地位を高めるために、いくつかの有機的および無機的な戦略を採用しています。たとえば、2020年7月、ドクター・レディーズ・ラボラトリーズは、2mgと4mgの強さで、アメリカ市場で市販のニコチン・ポラクリレックス・ロゼンジを発売しました。さらに、2020年11月、ペリゴ社は、アメリカがん協会(ACS)と提携して「禁煙はより良い」キャンペーンの4年目を終了しました。
禁煙補助薬市場レポートの範囲
レポート属性 | 詳細 |
---|---|
2021年の市場規模 | 234.1億米ドル |
2028年までの市場規模 | 640.3億米ドル |
世界のCAGR(2021年~2028年) | 15.5% |
歴史的なデータ | 2019-2020 |
予測期間 | 2022-2028 |
対象セグメント | 製品別
|
対象地域と国 | 北米
|
市場リーダーと主要企業プロフィール |
|
- サンプル PDF では、定性的および定量的な分析により、コンテンツの構造と情報の性質が紹介されています。
禁煙補助剤市場 – 製品別
- ニコチン置換療法
- 薬物
- 電子タバコ
- その他
禁煙補助薬市場 – エンドユーザー別
- 病院薬局
- オンラインチャンネル
- 小売薬局
- その他
禁煙補助薬市場 – 地域別
北米
- 私たち
- カナダ
- メキシコ
ヨーロッパ
- フランス
- ドイツ
- イタリア
- イギリス
- スペイン
- その他のヨーロッパ
アジア太平洋(APAC)
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- その他のアジア太平洋地域
中東およびアフリカ(MEA)
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- その他の中東およびアフリカ
南米と中米(詐欺)
- ブラジル
- アルゼンチン
- 南米および中米のその他の地域
企業プロフィール
- ファイザー株式会社
- グラクソ・スミスクライン
- ドクター・レディの研究所
- ジョンソン・エンド・ジョンソン・サービス株式会社
- シプラ株式会社
- ペリゴ カンパニー
- バウシュヘルスカンパニーズ株式会社
- グレンマーク
- 楽しんで
- ジュールラボ
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.
The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.
The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.
The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.
The List of Companies - Smoking Cessation Aids Market
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.